glp-1 compounding fda Compound versions of drugs for weight loss halted by Despite FDA ruling, compounded GLP-1s

Patient preference often determines format selection more than cost

When looking at the efficacy regardless of whether all patients stayed on treatment, an average weight loss of about 14% was achieved by people taking the Wegovy pill compared to about two per cent for the placebo

Batts, Plant-based diets for cardiovascular safety and performance in endurance sports

Shioshvili TJ and Kakonashvili AP: The surgical treatment of Peyronie's disease: replacement of plaque by free autograft of buccal mucosa

Nobody knows what it would be like to be on tirzepatide or semaglutide for five or 10 years, says Ingelfinger

While safety is a factor that contributes to the cancellation of trials, it is responsible for cancelling only 25% of phase II trials and less than 15% of phase III trials (6)